Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 01 October 2018 Name of applicant:Summit Therapeutics plcName of scheme:2005 EMI...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit to Highlight Potential of Precision Antibiotic Ridinilazole to Treat C. difficile Infection and Reduce Recurrent Disease at ID Week...
-
Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Second Quarter and Half Year Ended 31 July 2018 and Operational Progress ...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2018 on 20 September 2018 Oxford, UK,...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Therapeutics to Participate in Upcoming Investor Conferences Oxford, UK, and Cambridge, MA, US, 14 September 2018 – Summit...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’)Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets Discovery Enabled by Discuva Platform and...
-
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Nominates New Mechanism Antibiotic SMT-571 as its Lead Clinical Candidate for the Treatment of Gonorrhoea SMT-571 Designed to...
-
Summit Therapeutics plc(‘the Company’) Total voting rights Oxford, UK, and Cambridge, MA, US 3 September 2018 – Summit Therapeutics plc (AIM:SUMM, NASDAQ:SMMT), announces that in accordance with the...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Summit Therapeutics plc ("Summit", or the...
-
OXFORD, United Kingdom and CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that Mr Glyn Edwards, Chief Executive Officer, will present...